LH
Labcorp Holdings Inc.NYSEHealthcare$273.72+0.36%ClosedMarket Cap: $22.69B
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
25.89
PEG
1.48
P/B
2.62
P/S
1.63
EV/EBITDA
14.59
DCF Value
$367.37
FCF Yield
5.3%
Div Yield
1.1%
Margins & Returns
Gross Margin
28.2%
Operating Margin
10.7%
Net Margin
6.3%
ROE
10.3%
ROA
10.9%
ROIC
7.3%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $3.52B | $164.7M | $1.98 |
| FY 2025 | $13.95B | $876.5M | $10.46 |
| Q3 2025 | $3.56B | $261.1M | $3.12 |
| Q2 2025 | $3.53B | $237.9M | $2.84 |
Analyst Ratings
View AllPiper SandlerNeutral
2026-02-24JP MorganOverweight
2026-02-18BairdOutperform
2026-02-18JP MorganOverweight
2025-11-07UBSBuy
2025-10-29Trading Activity
Insider Trades
View AllCaveney Brian Jofficer: EVP, Pres of ED, CMO & CSO
SellMon Mar 30
Schechter Adam Hdirector, officer: President & CEO
SellMon Mar 30
Schechter Adam Hdirector, officer: President & CEO
SellMon Mar 30
GRAHAM ANITA Zofficer: EVP, CHRO
SellMon Mar 30
GRAHAM ANITA Zofficer: EVP, CHRO
SellMon Mar 30
Company Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NYSE
Beta
0.98
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.